Adoption and validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic dysfunction-associated steatotic liver disease in low-resource South Asian settings.

<h4>Introduction</h4>Patients with significant liver fibrosis (SF) are likely to progress to advanced chronic liver disease (ACLD). Therefore, liver-directed therapy is indicated. The European Association for the Study of the Liver-2024 (EASL) recommends annual screening of patients with diabetes fo...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Chamila Mettananda, Chamila Ranawaka, Thimira Egodage, Channaka Dantanarayana, Rumal Fernando, Lakmali Ranaweera, Dulani Kottahachchi, Shirom Siriwardhana, Arunasalam Pathmeswaran, Anuradha Dassanayake, Janaka de Silva
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Public Library of Science (PLoS) 2026-01-01
Serie:	PLoS ONE
Accesso online:	https://doi.org/10.1371/journal.pone.0341364
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Adoption and validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic dysfunction-associated steatotic liver disease in low-resource South Asian settings.

Documenti analoghi